Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tamoxifen and endometrial pathologies: a prospective study.

M Seoud1, A Shamseddine, A Khalil

  • 1Department of Obstetrics, American University of Beirut Medical Center, Beirut, Lebanon.

Gynecologic Oncology
|September 30, 1999
PubMed
Summary

Tamoxifen use in breast cancer patients can lead to endometrial pathologies, with abnormal bleeding being a key indicator. Routine endometrial thickness screening may not reliably detect these changes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 and stillbirth: direct vs indirect effect of the pandemic.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

Does COVID-19 cause pre-eclampsia?

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

Cesarean scar pregnancy is associated with abnormal implantation but not macroscopic myometrial invasion in early first trimester of pregnancy.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

Immunology of Aging: the Birth of Inflammaging.

Clinical reviews in allergy & immunology·2021
Same author

Maternal cardiovascular potential and kinetic energy indices in pre-eclamptic and small-for-gestational-age pregnancies.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

Perinatal and long-term outcome of fetal intracranial hemorrhage: systematic review and meta-analysis.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021

Area of Science:

  • Gynecology
  • Oncology
  • Pathology

Background:

  • Tamoxifen is a widely used medication for breast cancer treatment.
  • Endometrial pathologies are a known potential side effect of tamoxifen therapy.
  • Monitoring for endometrial changes is crucial in patients undergoing tamoxifen treatment.

Purpose of the Study:

  • To prospectively investigate the development of endometrial pathologies in women with breast cancer receiving tamoxifen.
  • To assess the correlation between tamoxifen use and specific endometrial abnormalities.
  • To evaluate the utility of endometrial thickness measurements in screening for these pathologies.

Main Methods:

  • Prospective follow-up of 80 women with breast cancer on tamoxifen.
  • Regular 6-month intervals included pelvic examinations, Pap smears, vaginal ultrasounds, and endometrial biopsies.

Related Experiment Videos

  • Data analysis focused on endometrial findings, patient demographics, and treatment duration.

    • Main Results:

    • Out of 67 evaluable patients, 50 were on tamoxifen for a mean of 15.8 months.
    • Abnormal endometrial findings (hyperplasia, polyps, adenocarcinoma) were observed in several patients, all presenting with abnormal vaginal bleeding.
    • No significant correlation was found between endometrial thickness and the presence or type of endometrial pathology.

    Conclusions:

    • Abnormal vaginal bleeding is a consistent symptom associated with endometrial pathologies in tamoxifen users.
    • Endometrial thickness measurements alone are not a reliable indicator for screening endometrial changes.
    • The routine screening value of endometrial thickness measurement for tamoxifen-treated patients remains controversial.